Mark Byrne, Founder & President
In 2004, Mr. Byrne founded PriMedicus Development, a successful professional services firm focused on life sciences business development. Mark Byrne is an experienced life sciences business leader with proven accomplishments in technology commercialization, leadership, general management, product development, and business and strategy development, who has experience identifying new growth opportunities, preparing winning NIH grant proposals, developing innovative technology, negotiating licensing and financing transactions, planning and executing mergers and acquisitions, and managing product teams. He has a noteworthy ability to build organizations that bridge clinical development, business management and customer needs.
Through PriMedicus, Mr. Byrne served as the interim CEO of AssureRx LLC, a business commercializing pharmacogenetics technology licensed from Cincinnati Children's Hospital and the Mayo Clinic. He led AssureRx from an out-licensing idea through a seed stage company to first commercial sale, completing technology in-licensing and raising capital from both angel investors and venture capital sources.
Previously Mr. Byrne was President and CEO of CardioEnergetics, Inc., a seed-stage medical device company developing treatments for congestive heart failure. As CEO he was responsible for developing and executing company plans and strategies, business and technology development, and financing.
Prior to joining CardioEnergetics, Mr. Byrne spent 9 years at Johnson and Johnson in a variety of business and product development leadership roles. He started his career working in research at Battelle Memorial Institute and holds engineering degrees with honors from the University of Dayton and The Ohio State University. He has seven issued U.S. Patents, others pending and is co-author on several journal articles and scientific posters.